메뉴 건너뛰기




Volumn 16, Issue 1, 2002, Pages 60-66

Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies

Author keywords

90Y; Anti CD19; Anti CD20; Monoclonal antibody; Non Hodgkin's lymphoma; Radioimmunotherapy

Indexed keywords

2 (4 ISOTHIOCYANATOBENZYL)DIETHYLENETRIAMINEPENTAACETIC ACID; ACTINIUM; B LYMPHOCYTE ANTIGEN; BISMUTH 213; CD19 ANTIGEN; CD20 ANTIGEN; CHELATING AGENT; IMMUNOLOGIC AGENT; IODINE 131; LUTETIUM; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B4; MONOCLONAL ANTIBODY C2B8; MONOCLONAL ANTIBODY CD19; MONOCLONAL ANTIBODY CD20; MONOCLONAL ANTIBODY Y 90; RADIOISOTOPE; RITUXIMAB; UNCLASSIFIED DRUG;

EID: 85009921562     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402320     Document Type: Article
Times cited : (56)

References (31)
  • 1
    • 0034612358 scopus 로고    scopus 로고
    • Emerging immunotherapies for non-Hodgkin lymphoma: The tortoise approaches the finish line
    • (2000) Ann. Intern. Med. , vol.132 , pp. 916-918
    • Press, O.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.